Doctors aiming to make a cheap and effective malaria
drug available across Africa have been awarded a $1.5m grant by the Gates
Malaria Partnership, based at the London School of Hygiene and Tropical
Medicine, which was established with $40m from the Bill & Melinda
Gates Foundation in 2000.

Experts will look at the best way of using the anti-malarial
drug Lapdap. Tom Kanyock, manager of product development for TDR, said:
“It appears that Lapdap would offer a safe and effective low -cost
alternative to the drugs currently available. Both drugs which make up
Lapdap have been around for a long time, and used for other things”.